Amrize (NYSE:AMRZ) Hits New 52-Week High After Insider Buying Activity

Amrize Ltd (NYSE:AMRZ)’s stock price hit a new 52-week high during mid-day trading on Tuesday after an insider bought additional shares in the company. The company traded as high as $65.72 and last traded at $63.5870, with a volume of 3114087 shares. The stock had previously closed at $65.13.

Specifically, CFO Ian A. Johnston purchased 1,200 shares of the business’s stock in a transaction on Thursday, February 19th. The shares were purchased at an average price of $63.92 per share, with a total value of $76,704.00. Following the completion of the purchase, the chief financial officer owned 18,544 shares in the company, valued at $1,185,332.48. This represents a 6.92% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Wall Street Analysts Forecast Growth

AMRZ has been the subject of several research reports. UBS Group increased their price objective on shares of Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, January 8th. Sanford C. Bernstein reissued an “outperform” rating and issued a $70.00 price target on shares of Amrize in a research note on Thursday, December 18th. Bank of America set a $58.00 price target on Amrize in a report on Monday, January 12th. Berenberg Bank set a $70.00 price target on Amrize in a report on Thursday, February 19th. Finally, Wells Fargo & Company upped their price objective on Amrize from $59.00 to $66.00 and gave the stock an “overweight” rating in a research report on Thursday, February 19th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $63.43.

Amrize Stock Performance

The company has a market capitalization of $36.44 billion and a price-to-earnings ratio of 26.78. The stock’s 50 day moving average price is $56.44 and its 200 day moving average price is $52.76. The company has a current ratio of 1.64, a quick ratio of 1.10 and a debt-to-equity ratio of 0.37.

Amrize (NYSE:AMRZ) last released its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.03. The company had revenue of $2.84 billion during the quarter, compared to analyst estimates of $2.95 billion. The firm’s quarterly revenue was down .4% compared to the same quarter last year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. MCF Advisors LLC acquired a new stake in shares of Amrize in the 4th quarter valued at approximately $27,000. Basepoint Wealth LLC acquired a new stake in Amrize in the fourth quarter valued at $33,000. Laurel Wealth Advisors LLC bought a new position in shares of Amrize in the 4th quarter valued at about $34,000. State of Wyoming bought a new position in shares of Amrize in the 3rd quarter valued at about $32,000. Finally, Itau Unibanco Holding S.A. increased its stake in shares of Amrize by 150.0% during the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after purchasing an additional 450 shares during the last quarter.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.